Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study

Katharina Wittmann,1 Cornel Sieber,2 Simon von Stengel,1 Matthias Kohl,3 Ellen Freiberger,2 Franz Jakob,4 Michael Lell,5 Klaus Engelke,1 Wolfgang Kemmler1 1Institute of Medical Physics, Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, 2Institute for Biomedicine of...

Full description

Bibliographic Details
Main Authors: Wittmann K, Sieber C, von Stengel S, Kohl M, Freiberger E, Jakob F, Lell M, Engelke K, Kemmler W
Format: Article
Language:English
Published: Dove Medical Press 2016-11-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/impact-of-whole-body-electromyostimulation-on-cardiometabolic-risk-fac-peer-reviewed-article-CIA
_version_ 1818695486391975936
author Wittmann K
Sieber C
von Stengel S
Kohl M
Freiberger E
Jakob F
Lell M
Engelke K
Kemmler W
author_facet Wittmann K
Sieber C
von Stengel S
Kohl M
Freiberger E
Jakob F
Lell M
Engelke K
Kemmler W
author_sort Wittmann K
collection DOAJ
description Katharina Wittmann,1 Cornel Sieber,2 Simon von Stengel,1 Matthias Kohl,3 Ellen Freiberger,2 Franz Jakob,4 Michael Lell,5 Klaus Engelke,1 Wolfgang Kemmler1 1Institute of Medical Physics, Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, 2Institute for Biomedicine of Aging, Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, 3Faculty of Medical and Life Sciences, University of Furtwangen, 4Musculoskeletal Research Center, University of Würzburg, Würzburg, 5Department of Radiology and Nuclear Medicine, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany Background: Sarcopenic obesity (SO) is characterized by a combination of low muscle and high fat mass with an additive negative effect of both conditions on cardiometabolic risk. The aim of the study was to determine the effect of whole-body electromyostimulation (WB-EMS) on the metabolic syndrome (MetS) in community-dwelling women aged ≥70 years with SO. Methods: The study was conducted in an ambulatory university setting. Seventy-five community-dwelling women aged ≥70 years with SO living in Northern Bavaria, Germany, were randomly allocated to either 6 months of WB-EMS application with (WB-EMS&P) or without (WB-EMS) dietary supplementation (150 kcal/day, 56% protein) or a non-training control group (CG). WB-EMS included one session of 20 min (85 Hz, 350 µs, 4 s of strain–4 s of rest) per week with moderate-to-high intensity. The primary study endpoint was the MetS Z-score with the components waist circumference (WC), mean arterial pressure (MAP), triglycerides, fasting plasma glucose, and high-density lipoprotein cholesterol (HDL-C); secondary study endpoints were changes in these determining variables. Results: MetS Z-score decreased in both groups; however, changes compared with the CG were significant (P=0.001) in the WB-EMS&P group only. On analyzing the components of the MetS, significant positive effects for both WB-EMS groups (P≤0.038) were identified for MAP, while the WB-EMS group significantly differed for WC (P=0.036), and the WB-EMS&P group significantly differed for HDL-C (P=0.006) from the CG. No significant differences were observed between the WB-EMS groups. Conclusion: The study clearly confirms the favorable effect of WB-EMS application on the MetS in community-dwelling women aged ≥70 years with SO. However, protein-enriched supplements did not increase effects of WB-EMS alone. In summary, we considered this novel technology an effective and safe method to prevent cardiometabolic risk factors and diseases in older women unable or unwilling to exercise conventionally. Keywords: sarcopenia, obesity, whole-body electromyostimulation, cardiovascular, metabolic risk, metabolic syndrome, community-dwelling, older people
first_indexed 2024-12-17T13:46:14Z
format Article
id doaj.art-a30cdee5ac954f21a262f90c4430d758
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-17T13:46:14Z
publishDate 2016-11-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-a30cdee5ac954f21a262f90c4430d7582022-12-21T21:46:09ZengDove Medical PressClinical Interventions in Aging1178-19982016-11-01Volume 111697170630114Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity studyWittmann KSieber Cvon Stengel SKohl MFreiberger EJakob FLell MEngelke KKemmler WKatharina Wittmann,1 Cornel Sieber,2 Simon von Stengel,1 Matthias Kohl,3 Ellen Freiberger,2 Franz Jakob,4 Michael Lell,5 Klaus Engelke,1 Wolfgang Kemmler1 1Institute of Medical Physics, Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, 2Institute for Biomedicine of Aging, Faculty of Medicine, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, 3Faculty of Medical and Life Sciences, University of Furtwangen, 4Musculoskeletal Research Center, University of Würzburg, Würzburg, 5Department of Radiology and Nuclear Medicine, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany Background: Sarcopenic obesity (SO) is characterized by a combination of low muscle and high fat mass with an additive negative effect of both conditions on cardiometabolic risk. The aim of the study was to determine the effect of whole-body electromyostimulation (WB-EMS) on the metabolic syndrome (MetS) in community-dwelling women aged ≥70 years with SO. Methods: The study was conducted in an ambulatory university setting. Seventy-five community-dwelling women aged ≥70 years with SO living in Northern Bavaria, Germany, were randomly allocated to either 6 months of WB-EMS application with (WB-EMS&P) or without (WB-EMS) dietary supplementation (150 kcal/day, 56% protein) or a non-training control group (CG). WB-EMS included one session of 20 min (85 Hz, 350 µs, 4 s of strain–4 s of rest) per week with moderate-to-high intensity. The primary study endpoint was the MetS Z-score with the components waist circumference (WC), mean arterial pressure (MAP), triglycerides, fasting plasma glucose, and high-density lipoprotein cholesterol (HDL-C); secondary study endpoints were changes in these determining variables. Results: MetS Z-score decreased in both groups; however, changes compared with the CG were significant (P=0.001) in the WB-EMS&P group only. On analyzing the components of the MetS, significant positive effects for both WB-EMS groups (P≤0.038) were identified for MAP, while the WB-EMS group significantly differed for WC (P=0.036), and the WB-EMS&P group significantly differed for HDL-C (P=0.006) from the CG. No significant differences were observed between the WB-EMS groups. Conclusion: The study clearly confirms the favorable effect of WB-EMS application on the MetS in community-dwelling women aged ≥70 years with SO. However, protein-enriched supplements did not increase effects of WB-EMS alone. In summary, we considered this novel technology an effective and safe method to prevent cardiometabolic risk factors and diseases in older women unable or unwilling to exercise conventionally. Keywords: sarcopenia, obesity, whole-body electromyostimulation, cardiovascular, metabolic risk, metabolic syndrome, community-dwelling, older peoplehttps://www.dovepress.com/impact-of-whole-body-electromyostimulation-on-cardiometabolic-risk-fac-peer-reviewed-article-CIASarcopenic ObesityWhole-Body ElectromyostimulationCardiometabolic RiskMetabolic SyndromeCommunity-DwellingOlder Woman
spellingShingle Wittmann K
Sieber C
von Stengel S
Kohl M
Freiberger E
Jakob F
Lell M
Engelke K
Kemmler W
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Clinical Interventions in Aging
Sarcopenic Obesity
Whole-Body Electromyostimulation
Cardiometabolic Risk
Metabolic Syndrome
Community-Dwelling
Older Woman
title Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
title_full Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
title_fullStr Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
title_full_unstemmed Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
title_short Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
title_sort impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity the randomized controlled formosa sarcopenic obesity study
topic Sarcopenic Obesity
Whole-Body Electromyostimulation
Cardiometabolic Risk
Metabolic Syndrome
Community-Dwelling
Older Woman
url https://www.dovepress.com/impact-of-whole-body-electromyostimulation-on-cardiometabolic-risk-fac-peer-reviewed-article-CIA
work_keys_str_mv AT wittmannk impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT sieberc impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT vonstengels impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT kohlm impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT freibergere impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT jakobf impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT lellm impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT engelkek impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy
AT kemmlerw impactofwholebodyelectromyostimulationoncardiometabolicriskfactorsinolderwomenwithsarcopenicobesitytherandomizedcontrolledformosasarcopenicobesitystudy